These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 933699)

  • 1. Effects of 4-methyl-alpha-ethyl-tyramine, 4, alpha-dimethyl-tyramine and tetrabenazine on the release and uptake of 5-hydroxytryptamine by human blood platelets in vitro.
    Campbell IC; Todrick
    Life Sci; 1976 May; 18(10):1091-7. PubMed ID: 933699
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-hydroxytryptamine and adenine uptake by human blood platelets following the release reaction.
    Wesemann W; von Pusch I
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):367-74. PubMed ID: 7268689
    [No Abstract]   [Full Text] [Related]  

  • 3. A simple superfusion technique for studying release of radiolabelled 5-hydroxytryptamine from blood platelets without interference of reuptake.
    Stoof JC; Mulder AH
    J Pharm Pharmacol; 1976 Apr; 28(4):323-4. PubMed ID: 6729
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the inhibition of 5-hydroxytryptamine uptake by methadone and its congeners in human platelets.
    Brase DA; Loh HH
    Biochem Pharmacol; 1976 Jul; 25(14):1684-6. PubMed ID: 942469
    [No Abstract]   [Full Text] [Related]  

  • 5. Release in vitro of 5-hydroxytryptamine from spindle cells of the domestic fowl.
    Sorimachi M; Kataoka K; Inouye A; Hori S
    Eur J Pharmacol; 1970 May; 10(2):243-8. PubMed ID: 4986567
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of drugs upon the uptake of 5-hydroxytryptamine and metaraminol by human platelets.
    Ahtee L; Saarnivaara L
    J Pharm Pharmacol; 1971 Jul; 23(7):495-501. PubMed ID: 4397447
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro effect of suloctidil on 14C-5-hydroxytryptamine uptake and liberation in rat platelets.
    de Gaetano G; Roncaglioni MC; Miragliotta G; Wielosz M; Garattini S
    Pharmacol Res Commun; 1977 Apr; 9(4):315-24. PubMed ID: 866374
    [No Abstract]   [Full Text] [Related]  

  • 8. The inhibition of human platelet 5-hydroxytryptamine uptake by tricyclic antidepressive drugs. The relation between structure and potency.
    Todrick A; Tait AC
    J Pharm Pharmacol; 1969 Nov; 21(11):751-62. PubMed ID: 4390834
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the effects of tetracyclic and tricyclic antidepressants on the serotonin uptake by human thrombocytes in vitro.
    Rysánek K; Benesová O; Spánková H
    Act Nerv Super (Praha); 1974; 16(4):307-8. PubMed ID: 4451016
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.
    Claassen V; Davies JE; Hertting G; Placheta P
    Br J Pharmacol; 1977 Aug; 60(4):505-16. PubMed ID: 302726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new modification for studying 5-HT uptake by blood platelets: a re-evaluation of tricyclic antidepressants as uptake inhibitors.
    Tuomisto J
    J Pharm Pharmacol; 1974 Feb; 26(2):92-100. PubMed ID: 4150838
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced release of biogenic amines from synaptosomes and blood platelets of guinea-pigs.
    Peyer M; Pletscher A; Affolter H
    Neuropharmacology; 1982 Sep; 21(9):831-8. PubMed ID: 6216418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of prothixen and related compounds on serotonin absorption by human thrombocytes].
    Oksenkrug GF
    Biull Eksp Biol Med; 1975 Aug; 80(8):74-7. PubMed ID: 1182309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the new 5-HT-uptake inhibitor paroxetine on hypermotility in rats produced by p-chloroamphetamine (PCA) and 4,alpha-dimethyl-7-tyramine (H 77/77).
    Lassen JB
    Psychopharmacology (Berl); 1978 Apr; 57(2):151-3. PubMed ID: 418448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: The effect of tyramine on the transport of 5-hydroxytryptamine in blood platelets.
    Genegke IK; Dalsgaard-Nielsen T
    Acta Pharmacol Toxicol (Copenh); 1973; 33(1):74-8. PubMed ID: 4801247
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonin (5-hydroxytryptamine) release and uptake in platelets from healthy persons and migrainous patients in attack-free intervals.
    Dalsgaard-Nielsen T; Genefke IK
    Headache; 1974 Apr; 14(1):26-32. PubMed ID: 4832733
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of 1-p-acetyldeoxyephedrine and 4-methyl- -ethyl-m-tyramine as to lowering of brain serotonin, and their antagonism by antidepressants.
    Dubnick B; Rucki EW; Salama AI
    Eur J Pharmacol; 1973 May; 22(2):121-8. PubMed ID: 4715214
    [No Abstract]   [Full Text] [Related]  

  • 18. [3H]imipramine binding of protein nature in human platelets: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors.
    Marcusson J; Tiger G
    J Neurochem; 1988 Apr; 50(4):1032-6. PubMed ID: 3279163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Org 6582, chlorimipramine and desmethylimipramine on the depletion of biogenic amines from the rat brain in vivo.
    Kafoe WF; Leonard BE
    Biochem Pharmacol; 1977 Jun; 26(11):1083-4. PubMed ID: 880260
    [No Abstract]   [Full Text] [Related]  

  • 20. Uptake, metabolism, storage, and release of 5-hydroxytryptamine in blood platelets.
    Da Prada M; Pletscher A
    Res Clin Stud Headache; 1970; 3():202-13. PubMed ID: 5527205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.